CME Group Inc.

CME
Real-time BATS EXCHANGE - 09/19 10:47:25 am
212.69USD
-1.55%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2018 2019 (e)
Sales 4 309 4 929
EBITDA 3 058 3 265
Operating profit (EBIT) 2 947 3 082
Pre-Tax Profit (EBT) 2 778 2 808
Net income 1 962 2 071
P/E ratio 32,9x 37,8x
EPS ( $ ) 5,71 5,72
Dividend per Share ( $ ) 2,80 5,25
Yield 1,49% 2,43%
Reference price ( $ ) 188,120 216,170
Announcement Date 02/14/2019
12:00pm
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2018 2019 (e)
Debt 3 027 1 499
Finance - -
Operating income (EBITDA) 3 058 3 265
Leverage
(Debt/EBITDA)
0,99x 0,46x
Capital Expenditure 117 182
Free Cash Flow (FCF) 2 324 2 636
Book Value Per Share (BVPS) ( $ ) 75,4 75,1
Cash Flow per Share (  ) - -
Announcement Date 02/14/2019
12:00pm
-
Balance Sheet Analysis
Financial Ratios
Size 2019e 2020e
Capitalization 77 410 M $ -
Entreprise Value (EV) 78 909 M $ 77 161 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 37,8x 32,1x
Capitalization / Revenue 15,7x 14,8x
EV / Revenue 16,0x 15,0x
EV / EBITDA 24,2x 22,3x
Yield (DPS / Price) 2,43% 2,78%
Price to book (Price / BVPS) 2,88x 2,85x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 62,5% 63,9%
Operating Leverage (Delta EBIT / Delta Sales) 0,32x 1,36x
Net Margin (Net Profit / Revenue) 42,0% 46,8%
ROA (Net Profit / Asset) 3,26% 3,39%
ROE (Net Profit / Equities) 9,12% 9,92%
Rate of Dividend 91,8% 89,4%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   3,69% 3,43%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) 12,9x 13,8x
Financial Leverage (Net Debt / EBITDA) 0,46x -
Price Earning Ratio
BNA & Dividende